ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,911Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 1290

$1.66M Total Retail Price of All Prescriptions

Rank: 16 out of 1290

1,721 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

4% of this provider’s 17,881 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

53% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SYNTHROID 3,033 2,778 10 1 28
SIMVASTATIN 1,826 1,695 2 1
METFORMIN HCL 1,250 1,108 3 10
CRESTOR 910 813 4 17
LEVOXYL 733 707 5 224
PEN NEEDLE 577 492 6 72
LEVOTHYROXINE SODIUM 513 476 7 4
ALENDRONATE SODIUM 500 486 8 39
GLYBURIDE-METFORMIN HCL 478 405 R 9 147
JANUVIA 429 407 10 82
LANTUS SOLOSTAR 424 329 11 88
FENOFIBRATE 408 342 12 98
NOVOLOG FLEXPEN 395 335 13 129
NOVOLOG MIX 70-30 FLEXPEN 388 370 10 14 213
ATORVASTATIN CALCIUM 386 351 15 23
LOVAZA 382 331 16 131
VITAMIN D2 363 314 17 301
SURE COMFORT 352 324 10 18 214
INSULIN SYRINGE 340 284 19 76
LOVASTATIN 324 303 20 45
LEVEMIR FLEXPEN 311 285 21 172
METHIMAZOLE 283 267 22 232
PRAVASTATIN SODIUM 267 234 23 42
GLIPIZIDE 249 226 24 81
GLIMEPIRIDE 248 217 25 57
ACTONEL 221 215 26 207
GLYBURIDE 216 191 R 27 87
NOVOLOG MIX 70-30 208 195 28 272
UNIFINE PENTIPS 186 131 10 29 471
LANTUS 172 145 30 67
TRICOR 163 137 31 194
VITAL-D RX 162 160 32 493
JANUMET 154 135 33 217
NOVOLOG 151 128 34 167
ZETIA 129 94 35 165
ACTOS 128 123 36 182
HUMALOG MIX 75-25 128 80 36 316
ONGLYZA 128 121 36 263
ULTICARE 118 102 10 39 519
VYTORIN 117 115 40 293
HUMALOG 103 80 41 148
METFORMIN HCL ER 99 96 42 135
PRANDIN 95 87 43 447
BONIVA 76 75 44 359
LIPITOR 70 70 45 195
NIASPAN 68 56 46 210
GEMFIBROZIL 68 62 46 210
TRILIPIX 67 57 48 313
HYDROCORTISONE 62 46 49 277
KOMBIGLYZE XR 60 43 50 525
LEVEMIR 58 49 51 256
PIOGLITAZONE HCL 58 52 R 51 326
IBANDRONATE SODIUM 56 45 53 290
GLIPIZIDE ER 56 30 53 206
CALCITRIOL 54 51 55 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.